LinkedIn-Logo.png

Simon Richardson, PhD FRSB

Director of the Exogenix lab and Reader in Drug Delivery and Membrane Trafficking at the University of Greenwich

Dr Richardson is the co-founder of the Exogenix laboratory and inventor of the Anthragenix and Exogenix delivery platforms. Dr Richardson undertook his PhD at The Centre for Polymer Therapeutics at the UCL School of Pharmacy reading intracellular delivery of ASOs. Following this he became a post-doctoral fellow at the Department of Molecular Physiology and Biophysics at the University of Iowa, where he studied the molecular regulation of endocytic vesicle fusion. Dr Richardson was later appointed a Visiting Assistant Professor at the Department of Anatomy and Cell Biology at the University of Iowa, where he initiated his own research program investigating the use of protein toxins as drug delivery tools. This research focus followed Dr Richardson back to the University of Greenwich, where he is now Reader in Drug Delivery and Membrane Trafficking and runs the Exogenix lab.

LinkedIn-Logo.png

Benedita Feron, BSc (Hons)

Research Assistant and Lab Manager

Benedita is the co-founder of the Exogenix laboratory, co-inventor of the Exogenix delivery platform and co-author of "The Delivery of Personalised, Precision Medicines via Synthetic Proteins" published in Drug Delivery Letters, as well as several international talks. Benedita was awarded "The best project in Bioscience" by the Royal Society of Biology (2019), "Best Overall Project" by The Ede and Ravenscroft (2019) and the "Inspiring Researcher" Award by Greenwich Research and Enterprise (2018) for her final year project "Generation of a streamlined reporter system for monitoring gene expression" and her research work whilst pursuing a BSc in Biomedical Science from the University of Greenwich. Benedita is currently responsible for managing the Exogenix laboratory and helping lead the Exogenix team, whilst pursuing her PhD "Life Driven by Code: Targeting Viral and Metabolic Disorders using Synthetic Biology", also at the University of Greenwich.

LinkedIn-Logo.png

Nourhan Mahmoud, BSc (Hons)

PhD student 

Nourhan obtained a dual certificate in Pharmacy and Pharmaceutical science from the MSA University and the University of Greenwich, respectively. After her BSc, Nourhan worked as a teaching assistant in the Pharmaceutical and Drug Design Department at MSA, where she co-authored the “Preparation, Characterization, Cytotoxicity and Biological Evaluation of 99mTc-Doxorubicin Epigallocatechingallate Functionalized Gold Nanoparticles as a New Generation of Theranostic Radiopharmaceutical". Nourhan was subsequently awarded an Mphil/PhD scholarship from the University of Greenwich where she is currently reading “Quantitating Pharmacology in Relation to Intracellular Distribution of ASOs and siRNA and Defining Transfection Efficiency”.

LinkedIn-Logo.png

Hadeer Abderlrahman, BSc (Hons)

PhD student

Hadeer is a PhD student at the Exogenix lab. Hadeer obtained a dual certificate in Pharmacy and Pharmaceutical science from the from MSA University and the University of Greenwich, respectively. During her BSc, Hadeer was an intern in the Immunology and Molecular Biology department at the U.S. Naval Medical Research unit no.3 (NAMRU-3) in the Middle East and Africa. After her BSc, she worked as a teaching assistant in the Analytical Chemistry Department at MSA in Egypt. Hadeer was subsequently awarded an Mphil/PhD scholarship from the University of Greenwich where she is currently reading “Assessing the effect of modulation in sub-cellular distribution upon the potential of a peptide to inhibit hormone dependent prostate cancer cells”. 

LinkedIn-Logo.png

Lina Marmolejo, BSc (Hons)

Laboratory Technician

Lina is a Pharmaceutical Biotechnology Master student at the University of Greenwich and laboratory technician at the Exogenix Lab. Lina studied Pharmaceutical Chemistry at ICESI University in Colombia where she evaluated the level of expression and phosphorylation of the Tau protein (microtubule associated protein) in a rat model of focal cerebral ischemia using glucosamine as a neuroprotection agent. Following this, Lina worked as a Chemical Analyst in the Stability and Validation Laboratories of Sanofi, where she acquired substantial HPLC and spectroscopy experience.  

© Exogenix Laboratory 2020